# Mojdeh Poul

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/mojdeh-poul
Canonical HTML page: https://getbiobrief.com/entity/mojdeh-poul

## Timeline

- **2026-02-26**: Q4 2025 Earnings — Company reports quarterly results and provides updates on quality remediation and 2026 outlook.
- **2025-01-06**: New CEO Appointment — Mojdeh Poul succeeds Jan De Witte as President and CEO of Integra LifeSciences.
- **2023-05-23**: Boston Plant Recall — Integra initiates voluntary recall of SurgiMend and PriMatrix products due to manufacturing issues.

## Recent coverage (1 stories)

### Integra LifeSciences Navigates Operational Recovery Amid CEO Transition
2026-02-26 22:45:01 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Integra LifeSciences reported its latest quarterly results, highlighting a period of strategic stabilization and operational remediation. While the company continues to address manufacturing challenges at its Boston facility, the appointment of new leadership and steady performance in its Codman Specialty Surgical segment signal a path toward long-term recovery.
Full story: https://getbiobrief.com/story/integra-lifesciences-iart-earnings-analysis-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.